Accuray to Bring Patient-First Cancer Treatment Innovations to ESTRO 37
Go back to Accuray to Bring Patient-First Cancer Treatment Innovations to ESTRO 37| Accuray Incorporated (NASDAQ: ARAY) | Delayed: 0.25 -0.01 (3.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.26 | 52 Week High | $7.24 | |||
| Open | $0.26 | 52 Week Low | $4.55 | |||
| Day High | $0.26 | P/E | N/A | |||
| Day Low | $0.25 | EPS | $-0.95 | |||
| Volume | 249,989 | |||||
